FDA approves Jubilant HollisterStier site for Definity production
The ultrasound contrast agent Definity is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to recover the delineation of the left
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.